This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
| less than a minute read

Parabilis Medicines' Record-Setting IPO

So pleased for my friend Mathai Mammen, founder Greg Verdine, and all of Parabilis Medicines on this remarkable milestone!

Para­bilis Med­i­cines said it would sell 33.5 mil­lion shares at $20 apiece, for a to­tal of $670 mil­lion.

Tags

erik lundh, insights, life sciences